ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Estrella Immunopharma Inc

Estrella Immunopharma Inc (ESLA)

1,095
-0,005
(-0,45%)
Fermé 06 Février 10:00PM
1,095
0,00
(0,00%)
Après les heures de négociation: 12:00AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
1,095
Prix Achat
1,03
Prix Vente
1,28
Volume échangé
1 535
1,07 Fourchette du Jour 1,10
0,63 Plage de 52 semaines 3,23
Cap du marché
Clôture Veille
1,10
Ouverture
1,10
Dernière Transaction
40
@
1.24
Dernière heure de transaction
Volume financier
US$ 1 669
VWAP
1,087
Volume moyen (3 m)
30 440
Actions en circulation
36 179 147
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-5,39
Bénéfice par action (BPA)
-0,2
Chiffre d'affairess
-
Bénéfice net
-7,31M

À propos de Estrella Immunopharma Inc

TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Wilmington, Delaware, USA
Fondé
-
Estrella Immunopharma Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker ESLA. Le dernier cours de clôture d'Estrella Immunopharma était de US$1,10. Au cours de la dernière année, les actions de Estrella Immunopharma ont été négociées dans une fourchette de prix de US$ 0,63 à US$ 3,23.

Estrella Immunopharma compte actuellement 36 179 147 actions en circulation. La capitalisation boursière d'Estrella Immunopharma est de US$39,80 million. Estrella Immunopharma a un ratio cours/bénéfice (ratio PE) de -5.39.

ESLA Dernières nouvelles

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat...

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) ("Estrella", “Estrella Immunopharma”, or the "Company"), a clinical stage biopharmaceutical company focused on developing CD19 and CD22-targeted...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.005-0.4545454545451.11.291.03139801.09090936CS
4-0.095-7.983193277311.191.291.0294551.12695431CS
120.282634.78581979320.81241.4850.7467304401.2170266CS
26-0.195-15.11627906981.291.5720.63792711.16352216CS
52-0.135-10.97560975611.233.230.63702701.420322CS
156-4.115-78.98272552785.215.620.63726831.5527846CS
260-4.115-78.98272552785.215.620.63726831.5527846CS

ESLA - Frequently Asked Questions (FAQ)

What is the current Estrella Immunopharma share price?
The current share price of Estrella Immunopharma is US$ 1,095
How many Estrella Immunopharma shares are in issue?
Estrella Immunopharma has 36 179 147 shares in issue
What is the market cap of Estrella Immunopharma?
The market capitalisation of Estrella Immunopharma is USD 39,8M
What is the 1 year trading range for Estrella Immunopharma share price?
Estrella Immunopharma has traded in the range of US$ 0,63 to US$ 3,23 during the past year
What is the PE ratio of Estrella Immunopharma?
The price to earnings ratio of Estrella Immunopharma is -5,39
What is the reporting currency for Estrella Immunopharma?
Estrella Immunopharma reports financial results in USD
What is the latest annual profit for Estrella Immunopharma?
The latest annual profit of Estrella Immunopharma is USD -7,31M
What is the registered address of Estrella Immunopharma?
The registered address for Estrella Immunopharma is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
Which industry sector does Estrella Immunopharma operate in?
Estrella Immunopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RFACURF Acquisition Corporation
US$ 10,12
(96,12%)
22,97k
IVVDInvivyd Inc
US$ 2,1001
(68,01%)
79,18M
ASSTAsset Entities Inc
US$ 0,810001
(47,46%)
170,15M
ACBAurora Cannabis Inc
US$ 5,37
(45,92%)
69,87M
RNAZTransCode Therapeutics Inc
US$ 8,885
(44,24%)
17,23M
VLCNVolcon Inc
US$ 1,82
(-43,13%)
3,88M
CSAICloudastructure Inc
US$ 8,12
(-37,44%)
250,67k
CAPTCaptiVision Inc
US$ 0,6819
(-35,06%)
8,88M
LRHCLa Rosa Holdings Corporation
US$ 0,2695
(-31,88%)
4,46M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,416999
(-30,91%)
1,23M
CYNCYNGN Inc
US$ 0,083
(16,90%)
449,48M
NVDANVIDIA Corporation
US$ 124,83
(5,21%)
263,48M
RIMEAlgorhythm Holdings Inc
US$ 0,0206
(-15,57%)
238,29M
ASSTAsset Entities Inc
US$ 0,810001
(47,46%)
170,15M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,051599
(17,81%)
143,98M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées